Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Software System Reduces Cesarean Complications

By HospiMedica staff writers
Posted on 19 Oct 2006
A computerized method of providing consistent and objective evaluation of labor progress can confirm the need for a cesarean section for women demonstrating symptoms of dystocia (slow labor).

The Calm Curve software program uses basic pelvic exam data and contraction information obtained during labor. More...
The patient's progress in labor (dilation and station vs time) is plotted along with the Calm Curve, with a representation of the mean and outer limits of a reference population under similar labor conditions. The comparisons are shown graphically and expressed in percentiles, giving an objective and reliable evaluation of labor progress. The calculations are updated at each exam and adjusted for changing labor conditions such as contraction frequency or epidural use. Calm Curve contributed to a safe fall in cesarean rates from 19.54-16.62% at 12 months, according to clinical studies involving some 11,000 first-time mothers in both the United States and Canada.

Another clinical situation in which the Calm Curve has reduced risk--involving the management of labor in women who have had a previous cesarean--is uterine rupture. Uterine rupture is a catastrophic complication with a reported incidence ranging from 0.2-1.5% in these women. In a retrospective analysis using the Calm Curve, abnormal labor progress was identified in 42% of cases of uterine rupture. This diagnosis was apparent, on average, five hours before the rupture, providing ample time for health care professionals to intervene and avoid this complication.

The Calm Curve is a product of LMS Medical Systems (Montreal, Canada). The system will be available through a seamless web offering, and medical personnel will be able to use the tool independently from, and irrespective of, any obstetrical or central hospital information system that may be in use.



Related Links:
LMS Medical Systems

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.